These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3409269)

  • 1. Vasopressin and 1-deamino-8-D-arginine-vasopressin (DDAVP) reduce elevated plasma catecholamine levels in rats with hypothalamic deafferentation.
    Kvetnanský R; Lichardus B; Jezová D; Oprsalová Z; Makara GB
    Cell Mol Neurobiol; 1988 Jun; 8(2):225-33. PubMed ID: 3409269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma catecholamines do not participate in pituitary-adrenal activation by immobilization stress in rats with transection of nerve fibers to the median eminence.
    Makara GB; Kvetnansky R; Jezova D; Jindra A; Kakucska I; Oprsalova Z
    Endocrinology; 1986 Oct; 119(4):1757-62. PubMed ID: 3019642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous vasopressin modulates activity of oxytocin neurons in homozygous Brattleboro rats.
    Cheng SW; North WG
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E556-62. PubMed ID: 3777164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?
    Jurcovicová J; Dobrakovová M; Oprsalová Z; Jezová D; Makara GB; Kvetnanský R
    Endocr Regul; 1991 Sep; 25(3):159-63. PubMed ID: 1764605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasopressin and its deamino-D-arginine analogue on renin release in the isolated perfused rat kidney.
    Konrads A; Hofbauer KG; Werner U; Gross F
    Pflugers Arch; 1978 Oct; 377(1):81-5. PubMed ID: 569283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
    Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
    Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma antidiuretic hormone levels and liver vasopressin receptors in the jerboa, Jaculus orientalis, and rat.
    Butlen D; Baddouri K; Rajerison RM; Guillon G; Cantau B; Jard S
    Gen Comp Endocrinol; 1984 May; 54(2):216-29. PubMed ID: 6329898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA; Holmes MC; Makara GB; Kárteszi M; László FA
    Peptides; 1984; 5(3):519-22. PubMed ID: 6089144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of rat renal thick ascending limb cells to vasopressin.
    Elalouf JM; Sari DC; Roinel N; de Rouffignac C
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2407-11. PubMed ID: 3353389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of plasminogen activator releasing activity in the neurohypophysis.
    Colucci M; Stassen JM; Salwa J; Collen D
    Br J Haematol; 1984 Oct; 58(2):337-46. PubMed ID: 6541053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vasopressin on noradrenaline-induced cyclic AMP accumulation in rat brain slices.
    Hamburger-Bar R; Newman ME
    Pharmacol Biochem Behav; 1985 Feb; 22(2):183-7. PubMed ID: 2984701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine vasopressin increases intracellular calcium ion concentration in isolated mouse collecting tubule cells: distinct mechanism of action through V2 receptor, but independent of adenylate cyclase activation.
    Naruse M
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):337-47. PubMed ID: 1635278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM; Dantzer R; Mormède P; Le Moal M
    Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.